The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer
Open accessAbstract
Moloney Murine Leukemia Virus (MoMuLV) causes T cell neoplasms in rodents but is not known to be a pathogen in primates. The core protein and enzyme genes of the MoMuLV genome together with an amphotropic envelope gene are utilized to engineer the cell lines that generate retroviral vectors for use in current human gene therapy applications. We developed a producer clone that generates a very high concentration of retroviral vector particles to optimize conditions for gene insertion into pluripotent hematopoietic stem cells. This producer cell line also generates a much lower concentration of replication-competent virus that arose through recombination. Stem cells from rhesus monkeys were purified by immunoselection with an anti-CD34 antibody, incubated in vitro for 80-86 h in the presence of retroviral vector particles with accompanying replication-competent virus and used to reconstitute recipients whose bone marrow had been ablated by total body irradiation. The retroviral vector genome was detected in circulating cells of five of eight transplant recipients of CD34+ cells and in the circulating cells of two recipients of infected, unfractionated bone marrow mononuclear cells. Three recipients of CD34+ cells had a productive infection with replication-competent virus. Six or seven mo after transplantation, each of these animals developed a rapidly progressive T cell neoplasm involving the thymus, lymph nodes, liver, spleen, and bone marrow. Lymphoma cells contained 10-50 copies of the replication-competent virus, but lacked the retroviral vector genome. We conclude that replication-competent viruses arising from producer cells making retroviral vectors can be pathogenic in primates, which underscores the importance of carefully screening retroviral producer clones used in human trials to exclude contamination with replication-competent virus.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although viral vectors have been widely used in the delivery of the CRISPR/Cas9 system in vitro and in vivo, their fundamental shortcomings, such as the risk of carcinogenesis, limited insertion size, immune responses and difficulty in large-scale production, severely limit their further applications.”
From Non-viral delivery systems for CRISPR/Cas9-based genome editing: challenges and opportunities (2018) · cites this paper as [71]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Cloning: A Laboratory Manual
Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589
Kishimoto, T. (1989) · Blood · doi:10.1182/blood.v74.1.1.bloodjournal7411 · Cited by 2,068
Improved retroviral vectors for gene transfer and expression.
Miller, A. D., & Rosman, G. J. (1989) · PubMed · Cited by 1,990
Mann, R., Mulligan, R. C., & Baltimore, D. (1983) · Cell · doi:10.1016/0092-8674(83)90344-6 · Cited by 1,776
Miller, A. D., & Buttimore, C. (1986) · Molecular and Cellular Biology · doi:10.1128/mcb.6.8.2895-2902.1986 · Cited by 1,371
Granulocyte colony-stimulating factor and its receptor
Demetri, G. D., & Griffin, J. D. (1991) · Blood · doi:10.1182/blood.v78.11.2791.2791 · Cited by 1,066
A safe packaging line for gene transfer: separating viral genes on two different plasmids
Markowitz, D., Goff, S. P., & Bank, A. (1988) · Journal of Virology · doi:10.1128/jvi.62.4.1120-1124.1988 · Cited by 1,062
Danos, O., & Mulligan, R. C. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.17.6460 · Cited by 898
Yang, Y., Ciarletta, A. B., Temple, P. A., Chung, M. P., Kovacic, S., Witek-Giannotti, J. S., Leary, A. C., Kriz, R., Donahue, R. E., Wong, G. G., et al. (1986) · Cell · doi:10.1016/0092-8674(86)90360-0 · Cited by 766
Self-citationPrimary structure and functional expression of rat and human stem cell factor DNAs
Martin, F. H., Suggs, S. V., Langley, K. E., Lu, H. S., Ting, J., Okino, K. H., Morris, C. F., McNiece, I., Jacobsen, F. W., Mendlaz, E. A., et al. (1990) · Cell · doi:10.1016/0092-8674(90)90301-t · Cited by 719
Flagged first, then by citations
Cited by
Sorted by citations
Items 401–500 of 525
Müller, L., Milsom, M. D., & Williams, D. A. (2010) · Springer eBooks · doi:10.1007/978-1-4419-7656-7_6 · Cited by 2
Reuss, F. U., Berdel, B., Heber, R., & Ploss, M. (2002) · Gene Therapy · doi:10.1038/sj.gt.3301785 · Cited by 2
Planelles, V. (2003) · Humana Press eBooks · doi:10.1385/1-59259-393-3:273 · Cited by 2
[Efficacy of RNA interference mediated by cationic liposomes].
Wu, H., Zhen, Y., Zhang, S., Zhao, Y., Sun, Y., Guo, X., Wang, E., Liu, Z., & Sun, Y. (2015) · PubMed · Cited by 2
Pagès, J., & Danos, O. (2003) · CRC Press eBooks · doi:10.1201/9780203912331.ch9 · Cited by 9
Cornetta, K. G., Koop, S., Nance, E., House, K. D., & Duffy, L. (2019) · Methods in molecular biology · doi:10.1007/978-1-0716-0146-4_13 · Cited by 2
SAFETY OF RETROVIRAL VECTORS IN GENE THERAPY
Bogoslovskaya, E. V., Glazkova, D. V., Shipulin, G. A., & Покровский, В. В. (2012) · Annals of the Russian academy of medical sciences · doi:10.15690/vramn.v67i10.417 · Cited by 2
Chapter 28. Human Gene Therapy
McGarrity, G. J., & Chiang, Y. L. (1993) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(08)60898-2 · Cited by 2
Herrmann, F., Kiehntopf, M., Brach, M. A., Carstanjen, D., & von Schilling, C. (1995) · Journal of Molecular Medicine · doi:10.1007/bf00188140 · Cited by 2
Bank, A. (1995) · Medical Oncology · doi:10.1007/bf01571191 · Cited by 2
London, C. W. (2005) · Cited by 2
Preparation of Fetal Islets for Transplantation: Importance of Growth Factors
Hullett, D. A., MacKenzie, D. A., Alam, T., & Sollinger, H. W. (1995) · Springer eBooks · doi:10.1007/978-1-4615-1981-2_3 · Cited by 2
Gene transfer: A prelude to gene therapy
Boyd, A. L. (1998) · Methods in Cell Science · doi:10.1023/a:1009752302208 · Cited by 2
Regulatory Aspects in the Development of Gene Therapies
Aurigemma, R. E., Tomaszewski, J. E., Ruppel, S., Creekmore, S. P., & Sausville, E. A. (2005) · Humana Press eBooks · doi:10.1007/978-1-59259-785-7_29 · Cited by 2
Retroviral Vectors for Gene TransferPreprint
Cornetta, K. G., Pollok, K. E., & Miller, A. D. (2008) · Cold Spring Harbor Protocols · doi:10.1101/pdb.top29 · Cited by 2
Complementation cell lines for viral vectors to be used in gene therapy
Mehtali, M. (1996) · Cytotechnology · doi:10.1007/bf00749754 · Cited by 2
Coles, R. E., Boyle, T. J., Kurtzberg, J., Stewart, A. K., Peters, W. P., & Lyerly, H. K. (1993) · Surgical Oncology · doi:10.1016/0960-7404(93)90038-z · Cited by 2
Transfer of the MDR-1 Gene into Hematopoietic Cells
Bank, A., Ward, M., & Hesdorffer, C. (1999) · KARGER eBooks · doi:10.1159/000061988 · Cited by 2
7 Cytokine gene transfer in the therapy of malignancy
Heslop, H. E. (1994) · Baillière s Clinical Haematology · doi:10.1016/s0950-3536(05)80010-1 · Cited by 2
Gene therapy: from retrovirus to triplex DNA repair
Becker, Y., & Darai, G. (1997) · Journal of Molecular Medicine · doi:10.1007/s001090050109 · Cited by 2
Candidate gene analysis of 3D dental phenotypes in patients with malocclusion
Weaver, C. A., Moreno, L. M., Southard, T. E., Allareddy, V., & Holton, N. E. (2014) · doi:10.17077/etd.imj3h3h6 · Cited by 2
Desenvolvimento de linhas celulares produtoras de vectores retrovirais para terapia génica
Tomás, H. A. (2010) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · Cited by 2
Salmons, B., Günzburg, W. H., Janka, I., & Brem, G. (1996) · Journal of Animal Breeding and Genetics · doi:10.1111/j.1439-0388.1996.tb00630.x · Cited by 2
Viral Evaluation of Animal Cell Lines Used in Biotechnology
Shepherd, A. J., & Smith, K. T. (2003) · Humana Press eBooks · doi:10.1385/0-89603-547-6:23 · Cited by 2
Viral vectors for gene delivery
Liang, K. J., & Samulski, R. J. (2015) · doi:10.4155/fseb2013.14.165 · Cited by 2
Retroviral Vectors in Gene Therapy
Miller, A. D. (2006) · Encyclopedia of Life Sciences · doi:10.1038/npg.els.0005741 · Cited by 2
Current Status of Retroviral Vector Mediated Gene Transfer into Human Hematopoietic Stem Cells
Elwood, N. J., & Smith, C. A. (2001) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428190109057950 · Cited by 2
Gene delivery using chemical methods
Bhatt, P., Surti, N. I., & Mahajan, A. N. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-27416-9.00008-3 · Cited by 1
van der Kuyl, A. C. (2026) · Pathogens · doi:10.3390/pathogens15010104 · Cited by 1
Gene Transfer and Tolerance Induction
Wong, W., Fry, J. W., Hyde, K., Morris, P. J., & Wood, K. (1998) · Springer eBooks · doi:10.1007/978-3-642-72140-3_31 · Cited by 1
Human Gene Therapy: Review and Outlook
McGarrity, G. J. (1998) · Springer eBooks · doi:10.1007/978-3-642-80412-0_33 · Cited by 1
Polyamine-Based Agents for Gene and siRNA Transfer
Blagbrough, I. S., Metwally, A. A., & Ahmed, O. A. A. (2011) · Royal Society of Chemistry eBooks · doi:10.1039/9781849733090-00205 · Cited by 1
Bollard, C. M., Russell, C., Cruz, Y. J. T., & Brenner, M. K. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4377-0271-2.00019-5 · Cited by 1
Tente, W. E. (2011) · Elsevier eBooks · doi:10.1016/b978-0-08-088504-9.00217-8 · Cited by 1
Wiltshire, T. D., Milosevic, D., Jacob, E. K., Grebe, S. K., & Dietz, A. B. (2021) · Cytotherapy · doi:10.1016/j.jcyt.2020.12.012 · Cited by 1
Retroviruses and Xenotransplantation
Weiss, R. A. (2014) · ASM Press eBooks · doi:10.1128/9781555818043.ch13 · Cited by 1
Sources and Methods for Obtaining Stem and Progenitor Cells
Donahue, R. E., Kuramoto, K., & Dunbar, C. E. (2005) · Current Protocols in Immunology · doi:10.1002/0471142735.im22a01s66 · Cited by 1
Self-citationGene Therapy for HIV Infection
Poznansky, M. C., McClure, M. O., & Adams, G. B. (2001) · Biotechnology Set · doi:10.1002/9783527620999.ch21d · Cited by 1
High, K. A. (1998) · Wiley eBooks · doi:10.1002/0471223956.ch15 · Cited by 1
Update on the Use of Genetically Modified Hematopoietic Stem Cells for Cancer Therapy
Kim, E. U., WILKE, L. G., & Mulé, J. J. (2002) · Elsevier eBooks · doi:10.1016/b978-012437551-2/50016-1 · Cited by 1
Guidelines for Trials of Gene Therapy and Somatic Gene Therapy in Cardiovascular Disease
Hoeg, J. M. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00266-5 · Cited by 1
FDA Guidance Document on Monitoring Delayed Adverse Events a Good First Start
Williams, D. A. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.10.011 · Cited by 1
Parvoviral Vectors for Human Hematopoietic Gene Therapy
Srivastava, A. (1999) · Blood cell biochemistry · doi:10.1007/978-1-4615-4889-8_4 · Cited by 1
Reuss, F. U., Berdel, B., Heber, R., & Bantel‐Schaal, U. (2002) · Journal of Medical Virology · doi:10.1002/jmv.10202 · Cited by 1
Gene therapy in pediatric oncology
Benaim, E., & Sorrentino, B. P. (1996) · Investigational New Drugs · doi:10.1007/bf00173685 · Cited by 1
Cellular gene therapy: a credible odyssey
Klein, H. G. (1997) · Transfusion · doi:10.1046/j.1537-2995.1997.37797369440.x · Cited by 1
Gene Therapy for Cancer: Prospects for the Treatment of Lung Tumours
Green, N. K., Gilligan, M. G., Kerr, D. J., Searle, P. F., & Young, L. S. (1999) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8784-7_10 · Cited by 1
Genetic Approaches To Adoptive Cellular Immunotheraphy
Salas, A. P., & Chang, A. E. (1998) · Surgical Oncology Clinics of North America · doi:10.1016/s1055-3207(18)30257-6 · Cited by 1
Kohn, D. B., Carter, B. J., Grandi, P., & Glorioso, J. C. (2009) · Wiley eBooks · doi:10.1128/9781555815981.ch16 · Cited by 1
Safety Considerations in the Development of New Retroviral and Adenoviral Vectors for Gene Therapy
Morgan, D., Forgie, I., Ostrove, J. M., & Wisher, M. H. (2006) · Kluwer Academic Publishers eBooks · doi:10.1007/0-306-46860-3_95 · Cited by 1
Adoptive T‐cell Therapy for Malignancy in the Setting of Hematopoietic Cell Transplantation
Forman, S. J., Kalos, M. D., & June, C. H. (2015) · Wiley eBooks · doi:10.1002/9781118416426.ch69 · Cited by 1
Growth Hormone Gene Therapy Using Encapsulated Myoblasts
Ismail, N., Hortelano, G., & Al-Hendy, A. A. (1999) · Birkhäuser Boston eBooks · doi:10.1007/978-1-4612-1586-8_27 · Cited by 1
Pollok, K. E., & Williams, D. A. (1998) · Humana Press eBooks · doi:10.1007/978-1-4757-2778-4_27 · Cited by 1
Patience, C. (1999) · Elsevier eBooks · doi:10.1016/b978-012200741-5/50024-6 · Cited by 1
Collins, M. K., & Porter, C. (1999) · Blood cell biochemistry · doi:10.1007/978-1-4615-4889-8_3 · Cited by 1
Retroviruses in Human Gene Therapy
Pedersen, F. S., Bahrami, S., & Duch, M. (2014) · Encyclopedia of Life Sciences · doi:10.1002/9780470015902.a0001002.pub3 · Cited by 1
Retroviruses in Human Gene Therapy
Pedersen, F. S., & Duch, M. (2003) · Encyclopedia of Life Sciences · doi:10.1038/npg.els.0001002 · Cited by 1
Retroviral Vectors From Laboratory Tools to Molecular Medicines
Vile, R. G., Tuszynski, A., & Castleden, S. (1998) · Springer protocols handbooks/Springer protocols · doi:10.1007/978-1-59259-642-3_18 · Cited by 1
Novel Systems for the Study of Human Disease
OECD (1998) · OECD eBooks · doi:10.1787/9789264162389-en · Cited by 1
Safe, Efficient Production of Retroviral Vectors
Kotani, H., & McGarrity, G. J. (1999) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-59990-3_9 · Cited by 1
Gentherapie als mögliche Behandlungsstrategie für kardiovaskuläre Erkrankungen
von der Leyen, H. E., & Dzau, V. J. (1995) · Springer eBooks · doi:10.1007/978-3-642-93558-9_41 · Cited by 1
Accidental Formation of Replication-Competent Viruses from Gene Transfer by Retroviral Vectors
Klehr-Wirth, D., Wirth, M., Grannemann, R., Münk, C., & Häuser, H. (1996) · Springer eBooks · doi:10.1007/978-3-642-61460-6_11 · Cited by 1
Askou, A. L., & Corydon, T. J. (2015) · Springer eBooks · doi:10.1007/978-1-4939-2389-2_3
Gene Therapy: A New Perspective for the Treatment of Malignant Melanoma
Schadendorf, D., & Dummet, R. (1997) · Springer eBooks · doi:10.1007/978-3-642-60752-3_34
Cloning and characterization of MRI, a modulator of retroviral infection
Agarwal, S. (2009) · University of Minnesota Digital Conservancy (University of Minnesota)
Gene therapy — an alternative approach for anti-cytokine therapies
Rogy, M. A. (1999) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8755-7_18
Herrmann, F., Kiehntopf, M., & Brach, M. A. (1995) · Springer eBooks · doi:10.1007/978-3-642-79782-8_7
Thérapie génique des déficits immunitaires héréditaires
Fischer, A., Basile, G. D. S., Santo, J. P. D., Hacein‐Bey‐Abina, S., Sharara, L. I., & Cavazzana, M. (1996) · Archives de Pédiatrie · doi:10.1016/0929-693x(96)85997-5
A non-invasive QPCR method monitoring DNA based therapy of bladder cancer patients
Ayesh, S. K., Abu-lail, R., & HOCHBERG, A. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.02.015
Gene Transfer to Hematopoietic Cells: Progress and Problems
Dunbar, C. E. (1998) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199809058616
Self-citationApport des biothérapies anticancéreuses dans le traitement des leucémies de l’enfant
Rousseau, R. F., Bollard, C. M., & Heslop, H. (2002) · Archives de Pédiatrie · doi:10.1016/s0929-693x(01)00767-9
Transcriptional inactivation of amphotropic murine leukemia virus replication in human cells
Ploß, M., Berdel, B., Heber, R., & Reuss, F. U. (2002) · Journal of Medical Virology · doi:10.1002/jmv.10274
Wu, S.-C., Liu, H., & Hong, W. W. L. (2005) · Enzyme and Microbial Technology · doi:10.1016/j.enzmictec.2005.06.022
Gene therapy applications for lumbar fusion surgery
Scaduto, A. A., & Wang, J. C. (2000) · Operative Techniques in Orthopaedics · doi:10.1016/s1048-6666(00)80033-6
Patent Update: Biologicals & Immunologicals: Advances in vector systems for gene therapy
Hodgson, C. P. (1995) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.5.5.459
Gene Therapy Strategies for Colorectal Cancer
Menon, A. G., van der Eb, M. M., Kuppen, P. J. K., & van de Velde, C. J. �. (2002) · Humana Press eBooks · doi:10.1007/978-1-59259-160-2_42
Principles of gene therapy: prospects for the treatment of head and neck cancer
Green, N. K., & McNeish, I. A. (1998) · The Journal of Laryngology & Otology · doi:10.1017/s0022215100142082
Rogy, M. A., Beinhauer, B. G., & Fang, M. (2000) · European surgery. Supplement/European surgery · doi:10.1007/bf02949260
Overview:In VivoExpression of Human Genes
Canonico, A. E., & Brigham, K. L. (1993) · Current Opinion on Therapeutic Patents · doi:10.1517/13543776.3.10.1487
Utilisation des virus comme vecteurs de thérapie génique
Latta‐Mahieu, M., Perricaudet, M., & Yeh, P. (1996) · Revue Française des Laboratoires · doi:10.1016/s0338-9898(96)80186-7
Choi, Y. J., Jeon, Y. H., Paik, J. H., Ko, J., Choi, D. H., Chung, J. K., & Kim, C. W. (2010) · Molecular Imaging · doi:10.2310/7290.2010.00010
Vector-based antiviral therapy
Ensser, A. (2006) · Springer eBooks · doi:10.1007/978-0-387-31047-3_19
Bonini, C., & Bordignon, C. (1999) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-7011-5_13
Recombinant Adeno-Associated Virus (r AAV) Vectors
Hallek, M. J., Wendtner, C., Kotin, R. M., Michl, D., & Winnacker, E. ‐. (1999) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-7011-5_6
Progress Towards the Clinical Application of Somatic Cell Gene Therapy
Bordignon, C. (1993) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-5663-8_48
Vector systems for gene delivery.
Funato, T. (1995) · Drug Delivery System · doi:10.2745/dds.10.91
New packaging cells based on the: adapted variant of the Rous sarcoma virus
Kaida, I. V., Serov, S. M., Michailik, A. A., Boltovets, P. M., Kashuba, V. I., & Rynditch, A. V. (1999) · Biopolymers and Cell · doi:10.7124/bc.000508
Biomedical applications of magnesium phosphate nanoparticles
Nabiyouni, M. (2014) · OhioLink ETD Center (Ohio Library and Information Network)
The Scope of Viral Vectors for the Transduction of Haemopoietic Cells
Lea, N. C., & Mufti, G. J. (1998) · Hematology · doi:10.1080/10245332.1998.11746378
Parvovirus Vectors for the Gene Therapy of Cancer
Wong, K. K., & Chatterjee, S. (2002) · Elsevier eBooks · doi:10.1016/b978-012437551-2/50004-5
Gene Marking to Establish the Biology of Minimal Residual Disease and Relapse
Brenner, M. K. (1998) · Hämatologie und Bluttransfusion · doi:10.1007/978-3-642-71960-8_91
Genetic Modulation of Effector Cells to Enhance GVL Effects
Heslop, H. E., & Moriwaki, K. (2000) · CRC Press eBooks · doi:10.1201/9780203909508-21
Principles of cancer gene therapy
Vieweg, J. (1996)
Biosafety in Handling Gene Transfer Vectors
Braun, A. G. (2002) · Current Protocols in Human Genetics · doi:10.1002/0471142905.hg1201s35
Gene Transfer to HSCs: Finding the Leukemia in Murine Leukemia Viruses
Cornetta, K. G. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2019.05.003
AAV-Nrf2 Mediated Rescue of Oxidative Stress in Mouse Models
Liang, K. J. (2015) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/tmc2-r921
Kerr, R. H. (2018) · UWA Profiles and Research Repository (University of Western Australia) · doi:10.26182/5b5a7faca20eb
Metadata
- Authors
- Donahue, R. E., Kessler, S. W., Bodine, D., McDonagh, K., Dunbar, C., Goodman, S., Agricola, B., Byrne, E., Raffeld, M., & Moen, R.
- Affiliations
- National Institutes of Health (US)
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 1992-10-01
- Volume
- 176
- Issue
- 4
- Pages
- 1125-1135
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC2119385
- OpenAlex
- W2132859839
- Cited by
- 532
- References
- 42
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 3 · 2022: 8 · 2021: 4 · 2020: 3 · 2019: 5 · 2018: 10 · 2017: 7 · 2015: 8 · 2014: 11 · 2013: 5 · 2012: 9
- FWCI
- 17.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and Retrovirus Studies
- Health Sciences › Medicine › Surgery › Xenotransplantation and immune response
- Keywords
- Moloney murine leukemia virus, retroviral vectors, replication-competent virus, T-cell lymphoma, helper virus, retroviral gene transfer, CD34+ hematopoietic stem cells, bone marrow transplantation, rhesus monkeys, non-human primates, gene therapy safety, thymic lymphoma
- MeSH terms
- Animals, Antibodies, Monoclonal, Antigens, Differentiation, Base Sequence, Cells, Cultured, DNA, Neoplasm, DNA, Viral, Globins, Helper Viruses, Macaca mulatta, Molecular Sequence Data, Moloney murine leukemia virus, Oligodeoxyribonucleotides, Time Factors, Transfection, Virus Replication, Antigens, CD, Bone Marrow Transplantation, Lymphoma, T-Cell, Genome, Viral, Antigens, CD34
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review